Robert G. Spignesi Jr. - 08 Jul 2025 Form 4 Insider Report for RAPID MICRO BIOSYSTEMS, INC. (RPID)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Sean M. Wirtjes, Attorney-in-Fact for Robert G. Spignesi, Jr.
Issuer symbol
RPID
Transactions as of
08 Jul 2025
Net transactions value
-$116,976
Form type
4
Filing time
10 Jul 2025, 19:43:21 UTC
Previous filing
11 Mar 2025
Next filing
15 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Spignesi Robert G. Jr. PRESIDENT AND CEO, Director C/O RAPID MICRO BIOSYSTEMS, INC., 25 HARTWELL AVENUE, LEXINGTON /s/ Sean M. Wirtjes, Attorney-in-Fact for Robert G. Spignesi, Jr. 10 Jul 2025 0001853904

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPID Class A Common Stock Options Exercise $0 +25,144 +2.9% $0.000000 897,510 08 Jul 2025 Direct F1
transaction RPID Class A Common Stock Sale $38,021 -10,824 -1.2% $3.51 886,686 08 Jul 2025 Direct F2
transaction RPID Class A Common Stock Options Exercise $0 +25,144 +2.8% $0.000000 911,830 09 Jul 2025 Direct F1
transaction RPID Class A Common Stock Sale $39,480 -11,247 -1.2% $3.51 900,583 09 Jul 2025 Direct F2
transaction RPID Class A Common Stock Options Exercise $0 +25,145 +2.8% $0.000000 925,728 10 Jul 2025 Direct F1
transaction RPID Class A Common Stock Sale $39,475 -11,617 -1.2% $3.40 944,015 10 Jul 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired upon satisfaction of performance criteria underlying previously granted performance restricted stock units.
F2 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance restricted stock units.
F3 Includes 29,904 shares acquired under the Rapid Micro Biosystems, Inc. employee stock purchase plan on March 14, 2025.